New drug hope for rare Heart-Lung condition: sotatercept trial launches
NCT ID NCT07356778
First seen Jan 28, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This study tests whether adding the drug sotatercept to standard care can help adults with pulmonary arterial hypertension (PAH) caused by unrepaired congenital heart defects, including Eisenmenger syndrome. About 36 adults in Japan will be randomly assigned to receive either sotatercept injections plus usual vasodilator therapy or vasodilator therapy alone for 24 weeks. The main goal is to see if the combination improves how far participants can walk in six minutes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION OF CONGENITAL HEART DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Department of Cardiology, Keio University School of Medicine
RECRUITINGTokyo, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Department of Cardiology, Nagoya University Hospital
RECRUITINGNagoya, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Department of Cardiovascular Medicine, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
RECRUITINGOkayama, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
RECRUITINGKyoto, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Department of Cardiovascular Medicine, Kyorin University School of Medicine
RECRUITINGTokyo, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine
RECRUITINGSendai, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Division of Cardiovascular Medicine, Department of Internal Medicine, Showa University Graduate School of Medicine
RECRUITINGTokyo, Japan
Contact Email: •••••@•••••
Contact
-
Division of Cardiovascular Medicine, Kobe University Hospital
RECRUITINGKobe, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Kyushu University Hospital
RECRUITINGFukuoka, Not Required For This Country, 8150014, Japan
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
The Second Department of Internal Medicine, University of Occupational and Environmental Health
RECRUITINGFukuoka, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.